These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2459229)

  • 1. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule.
    Santos-Aguado J; Barbosa JA; Biro PA; Strominger JL
    J Immunol; 1988 Oct; 141(8):2811-8. PubMed ID: 2459229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule.
    Brenner MB; McLean J; Yang SY; van der Poel JJ; Pious D; Strominger JL
    J Immunol; 1985 Jul; 135(1):384-90. PubMed ID: 2582041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
    el-Zaatari FA; Sams KC; Taurog JD
    J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule.
    Hogan KT; Clayberger C; Le AX; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Dec; 141(11):4005-11. PubMed ID: 2460555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid genes between HLA-A2 and HLA-A3 constructed by in vivo recombination allow mapping of HLA-A2 and HLA-A3 polymorphic antigenic determinants.
    Sire J; Chimini G; Boretto J; Toubert A; Kahn-Perles B; Layet C; Sodoyer R; Lemonnier F; Jordan B
    J Immunol; 1988 Apr; 140(7):2422-30. PubMed ID: 2450922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two epitopes and one agretope map to a single HLA-A2 peptide recognized by H-2-restricted T cells.
    Martinon F; Cornille F; Gomard E; Fournie-Zaluski MC; Abastado JP; Roques BP; Levy JP
    J Immunol; 1989 May; 142(10):3489-94. PubMed ID: 2469716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenicity of HLA-A2 and HLA-B7. Loss and gain of serologic determinants induced by site-specific mutagenesis at residues 62 to 80.
    Doménech N; Santos-Aguado J; López de Castro JA
    Hum Immunol; 1991 Feb; 30(2):140-6. PubMed ID: 1708752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
    Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
    J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creation of an HLA-A2/HLA-Aw69 alloantigenic determinant on an HLA-A3 molecule by site-directed mutagenesis.
    Layet C; Kahn-Perles B; Pontarotti P; Ferrier P; Sire J; Lemonnier FA
    J Immunol; 1987 Apr; 138(7):2197-201. PubMed ID: 2435791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
    Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer.
    Ronchese F; Brown MA; Germain RN
    J Immunol; 1987 Jul; 139(2):629-38. PubMed ID: 3110276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants.
    Toubert A; Raffoux C; Boretto J; Sire J; Sodoyer R; Thurau SR; Amor B; Colombani J; Lemonnier FA; Jordan BR
    J Immunol; 1988 Oct; 141(7):2503-9. PubMed ID: 2459214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of novel class I histocompatibility antigens by interspecies exon shuffling.
    Engelhard VH; Yannelli JR; Evans GA; Walk SF; Holterman MJ
    J Immunol; 1985 Jun; 134(6):4218-25. PubMed ID: 2985705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional significance of two amino acid polymorphisms in the antigen-presenting domain of class I MHC molecules. Molecular dissection of Kbm3.
    Pullen JK; Hunt HD; Horton RM; Pease LR
    J Immunol; 1989 Sep; 143(5):1674-9. PubMed ID: 2788191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.